인쇄하기
취소

CGBio starts first clinical trial for next-generation stent for coronary artery

Published: 2017-03-24 14:58:41
Updated: 2017-03-24 14:58:41

CGBio(CEO Hyun-Seung Yoo) announced after the Ministry of Food and Drug Safety(MOHW) approved the clinical trial plan of drug-eluting stent for coronary artery, Professor Hyo-Soo Kim’s research team at Seoul National University Hospital started the clinical trial for the first time and the procedure went successful.

As chosen for the project supervised by the MOHW to support clinical trials fo...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.